Form 4 Filing for Envoy Medical, Inc. - Officer and Director Transactions

This filing details significant transactions by Brent T. Lucas, Chief Executive Officer and Director of Envoy Medical, Inc. (COCH). On June 19, 2026, Lucas acquired 1,000,000 stock options with an exercise price of $0.634 and 1,000,000 Restricted Stock Units (RSUs), both vesting under specific FDA approval conditions. The RSUs represent a contingent right to receive one share of Class A Common Stock each. Additionally, the filing discloses existing holdings and other derivative instruments, including various stock options and warrants with different vesting and expiration dates. Specifically, options to purchase 879,749 shares at $2.40 and 200,000 shares at $0.53 are noted, alongside warrants for 110,987 shares at $11.50, 37,500 shares at $0.40, and 62,500 shares at $0.40. Following these transactions, Lucas holds 329,946 shares of Class A Common Stock directly.